Showing 1671-1680 of 10035 results for "".
Optimized Practice Advertising
https://practicaldermatology.com/topics/practice-management/optimized-practice-advertising/19057/Internal marketing may be most effective for many practices, but other avenues are also important, says Page Piland. Recorded June 2014 @ Vegas Cosmetic Surgery.Word of Mouth Advertising Done Right
https://practicaldermatology.com/topics/practice-management/word-of-mouth-advertising-done-right/19064/Tracy Drumm, Vice President of IF Marketing shares insider tips for effective word of mouth advertising for the cosmetic or aesthetic practice.The Economical ADVANTAGE Diode Laser Treats Chest and Abs Hair In Under 5 Minutes
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-economical-advantage-diode-laser-treats-chest-and-abs-hair-in-under-5-minutes/19213/ADVANTAGE™ Diode Laser Hair Removal System, offers clinics an economical way to have speed and efficacy in a small footprint. The 10 x 30 mm handpiece delivers impressive speed for efficacious LHR as demonstrated by Dr. Melanie Palm. The male patient in this video has his unwanted chest and abs hairYour Website Architecture - Every Brick Counts, an Ekwa.com Educational Video
https://practicaldermatology.com/topics/practice-management/your-website-architecture-every-brick-counts/19340/An educational video explaining proper website architecture and menu placement for External uses. Visit Ekwa.com for more information.The Molecular Age in Dermatology and Dermatopathology
https://practicaldermatology.com/conferences/noah-worcester/the-molecular-age-in-dermatology-and-dermatopathology/57076/Alina Bridges, DO, discusses her presentation, “Beyond the Microscope: Integrating Molecular and Ancillary Studies in Dermatology,” from the Noah Worcester Dermatological Society’s 2026 Annual Meeting.Innovation in Androgenetic Alopecia
https://practicaldermatology.com/series/c-suite-chats/innovation-in-androgenetic-alopecia/54265/Diana Harbort, President of Cosmo Pharmaceuticals' Dermatology Division, discusses the need for new innovations in androgenetic alopecia and the promise of clascoterone for treating the condition.Dermwire TV: Ruxolitinib Cream 1.5% Effective for AD Improvement, Stapokibart Shows Promise
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-ruxolitinib-cream-15-effective-for-ad-improvement-stapokibart-shows-promise/49101/This episode highlights new research showing ruxolitinib cream 1.5% providing itch relief and broader atopic dermatitis (AD) improvement, as well as a post-hoc analysis finding safety and efficacy for stapokibart in elderly adults with AD; and Excellergy executives discuss how recent research validaDermwire TV: Topical Caffeine for Hair Growth, Tapinarof for Pediatric AD
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-topical-caffeine-for-hair-growth-tapinarof-for-pediatric-ad/48734/This episode highlights studies showing potential for topical caffeine in hair growth in patients with alopecia areata, as well as recent positive results for tapinarof cream 1% for children with AD. Also, Cutera CEO Taylor Harris talks with Practical Dermatology about the evolving needs of today’sIncreased APS Risk for Psoriasis Patients, Plus More
https://practicaldermatology.com/series/dermwire-tv/increased-aps-risk-for-psoriasis-patients-plus-more/39299/This episode highlights research showing increased risk for anti-phospholipid syndrome (APS) in patients with psoriatic disease, as well as research showing increased risks for tuberculosis in patients treated with immunosuppressants. The episode also features a clip from an in-depth discussion arouBiologics Preferred after MACE in PsO, Plus More
https://practicaldermatology.com/series/dermwire-tv/biologics-preferred-after-mace-in-pso-plus-more/37882/In this edition of DermwireTV, new research shows biologic use use after MACE is persistent, signaling strong patient preference; a new study shows that early stress may raise lifelong psoriasis risk; and a new C-Suite Chat highlights a new antibody showing promise in treating atopic dermatitis